LCTX vs AMGN: Which Stock is Better?

Side-by-side comparison of Lineage Cell Therapeutics Inc and Amgen Inc in 2026

Comparison Updated:

LCTX

Lineage Cell Therapeutics Inc

AMGN

Amgen Inc

$363.39

Key Metrics Comparison

MetricLCTXAMGNWinner
Market Cap$213.56M$188.67BAMGN
P/E RatioN/A24.33AMGN
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze LCTX

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LCTX or AMGN a better investment?

Comparing LCTX and AMGN: Lineage Cell Therapeutics Inc has a market cap of $213.56M while Amgen Inc has $188.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LCTX and AMGN?

LCTX (Lineage Cell Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LCTX or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: LCTX or AMGN?

Both LCTX and AMGN show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: LCTX or AMGN?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: LCTX or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $188.67B compared to $213.56M for LCTX.

Should I buy LCTX or AMGN in 2026?

Both LCTX and AMGN have investment merit. LCTX trades at $N/A while AMGN trades at $363.39. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LCTX and AMGN stock?

Key differences: Market Cap ($213.56M vs $188.67B), P/E Ratio (N/A vs 24.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy LCTX or AMGN in 2026?

The choice between LCTX and AMGN depends on your investment goals. AMGN shows higher revenue growth (0.0%). AMGN has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between LCTX and AMGN?

LCTX (Lineage Cell Therapeutics Inc) has a market cap of $213.56M, while AMGN (Amgen Inc) has a market cap of $188.67B. AMGN is the larger company by market value.

Popular Stock Comparisons